← Browse by Condition
Medical Condition
atopic dermatitis
Total Trials
13
Recruiting Now
13
Trial Phases
Phase 1, Phase 2, Phase 4
ClinicalMetric tracks all active clinical trials for atopic dermatitis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — atopic dermatitis Clinical Trials
How many clinical trials are currently recruiting for atopic dermatitis?
ClinicalMetric currently tracks 13 actively recruiting clinical trials for atopic dermatitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for atopic dermatitis?
atopic dermatitis research spans Phase 1 (1 trial), Phase 2 (4 trials), Phase 3 (2 trials), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a atopic dermatitis clinical trial?
Eligibility criteria for atopic dermatitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 4
Phase 3 2
Phase 4 2
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT03928431
Recruiting
Restoration of Microbiota in Neonates
Enrollment
300 pts
Location
Sweden
Sponsor
Karolinska Institutet
NCT06937788
Recruiting
Replication of the Heads Up Atopic Dermatitis Trial With Registry Data
Enrollment
240 pts
Location
Germany
Sponsor
Technische Universität Dresden
NCT07358156 Phase 1
Recruiting
A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.
Enrollment
519 pts
Location
Germany, United King...
Sponsor
Chong Kun Dang Pharmaceutical
NCT06096857 Phase 2
Recruiting
Cardamom and Topical Roseomonas in Atopic Dermatitis
Enrollment
120 pts
Location
United States
Sponsor
National Institute of Allergy ...
NCT06116526 Phase 4
Recruiting
Dupilumab De-escalation in Pediatric Atopic Dermatitis
Enrollment
30 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06996327
Recruiting
The Potential Role of Compounds Derived From Ultra-processed Foods in the Pathogenesis of Atopic Dermatitis in Pediatric Age
Enrollment
100 pts
Location
Italy
Sponsor
Federico II University
NCT05994976
Recruiting
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Enrollment
500 pts
Location
Canada
Sponsor
Innovaderm Research Inc.
NCT02365246 Phase 2
Recruiting
Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD)
Enrollment
15 pts
Location
Belgium
Sponsor
Universitaire Ziekenhuizen KU ...
NCT06850311 Phase 2, Phase 3
Recruiting
Herbal Ointment in Treating Atopic Dermatitis Topically
Enrollment
66 pts
Location
Taiwan
Sponsor
En Chu Kong Hospital
NCT07242638 Phase 2
Recruiting
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Enrollment
56 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
NCT06136767
Recruiting
Registry for Systemic Eczema Treatments
Enrollment
400 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06832618 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
Enrollment
240 pts
Location
United States, Belgi...
Sponsor
Incyte Corporation
NCT05042258 Phase 4
Recruiting
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
Enrollment
40 pts
Location
United States
Sponsor
Northwestern University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology